About Techcyte
Techcyte is a company based in Orem (United States) founded in 2014. Techcyte has raised $65.4 million across 6 funding rounds from investors including Zoetis, ARUP Laboratories and Mayo Clinic. Techcyte offers products and services including Fusion, SureView Cervical Cytology System, Frozen Section Suite, Parasitology Suite, and Bacteriology Suite. Techcyte operates in a competitive market with competitors including PathAI, Viz.ai, Deepcell, Deciphex and Aignostics, among others.
- Headquarter Orem, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Techcyte, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$65.4 M (USD)
in 6 rounds
-
Latest Funding Round
$15 M (USD), Series B
Apr 30, 2026
-
Investors
Zoetis
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Techcyte
Techcyte offers a comprehensive portfolio of products and services, including Fusion, SureView Cervical Cytology System, Frozen Section Suite, Parasitology Suite, and Bacteriology Suite.
Unified platform for clinical and anatomic pathology workflows.
AI-based system for detecting cervical cytology abnormalities.
AI-assisted tool for rapid frozen section analysis in diagnostics.
Platform for AI-driven detection of parasites in samples.
AI system for gram analysis and bacterial identification.
People of Techcyte
Unlock access to complete
Funding Insights of Techcyte
Techcyte has successfully raised a total of $65.4M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $15 million completed in April 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Techcyte
Techcyte has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Zoetis, ARUP Laboratories and Mayo Clinic.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Animal medicines, vaccines, and diagnostics are manufactured and supplied.
|
Locked | Locked | Locked | |
|
Clinical laboratory testing and healthcare advisory services are provided.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Techcyte
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Techcyte
Investment portfolio details for Techcyte
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Techcyte
Detailed financials for Techcyte
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Techcyte Comparisons
Peer comparison for Techcyte
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Techcyte
Techcyte operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PathAI, Viz.ai, Deepcell, Deciphex and Aignostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
|
|
| Locked | Locked | Locked |
AI and cloud-powered software for stroke care coordination is developed.
|
|
| Locked | Locked | Locked |
AI-powered single cell classification and isolation technology for clinical research
|
|
| Locked | Locked | Locked |
Digital pathology software is developed for clinical and veterinary productivity.
|
|
| Locked | Locked | Locked |
AI-based pathology diagnostic software is provided for medical analysis.
|
|
| Locked | Locked | Locked |
AI-based tools for pathological image analysis are provided to labs.
|
Detailed competitors of Techcyte
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Techcyte
Complete news archive for Techcyte
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Techcyte
Techcyte was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Techcyte is headquartered in Orem, United States. It is registered at Orem, Utah, United States.
Techcyte is a funded company, having raised a total of $65.4M across 6 funding rounds to date.
Techcyte was founded in 2014 in Orem, United States, within the healthcare technology sector. Digital microscopy images are analyzed through multiple AI platforms tailored for pathologists. Development focuses on tools for hematology tests, cervical cytology, and ova and parasites fecal examinations, applicable to both human and animal samples. A collaboration with Motic integrates whole slide scanning, workflow management, and reporting functionalities.
Techcyte's top competitors include Aignostics, Deciphex and Pictor Labs.
Techcyte offers Fusion, SureView Cervical Cytology System, Frozen Section Suite, Parasitology Suite, and Bacteriology Suite.
Techcyte has 3 investors. Key investors include Zoetis, ARUP Laboratories, and Mayo Clinic.